BIOEN.E — Biotrend Cevre ve Enerji Yatirimlari AS Cashflow Statement
0.000.00%
- TRY9.27bn
- TRY14.40bn
- TRY2.94bn
Annual cashflow statement for Biotrend Cevre ve Enerji Yatirimlari AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.24 | 577 | 1,372 | -87.6 | -1,382 |
| Depreciation | |||||
| Non-Cash Items | 3.91 | 180 | -1,015 | -2,212 | 701 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -364 | -254 | 589 | -41.9 | 481 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -326 | 800 | 1,585 | -1,532 | 702 |
| Capital Expenditures | -441 | -1,447 | -1,511 | -906 | -579 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.1 | -0.671 | 101 | 451 | 140 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -440 | -1,448 | -1,410 | -455 | -439 |
| Financing Cash Flow Items | -23.7 | -86.1 | -316 | -574 | -481 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 835 | 229 | -28.7 | 1,829 | -343 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 69.1 | -419 | 147 | -151 | -75.9 |